R L Krigel. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Agents/therapeutic useClinical Trials as TopicDose-Response Relationship, DrugHumansImmunotherapyInterferon Type I/therapeutic usePrognosisSarcoma, Kaposi/drug therapySarcoma, Kaposi/physiopathology
Substances： See more » Antineoplastic AgentsInterferon Type I
Year: 1984 PMID： 6398653 DOI： 10.1111/j.1749-6632.1984.tb37166.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691